How to achieve harmonisation of laboratory testing -The complete picture

Clinica Chimica Acta

Volumn 432, Issue , 2014, Pages 8-14

  Aarsand, Aasne K ^a,b   Sandberg, Sverre ^a,b,c  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b Haraldsplass Deaconess Hospital   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

External quality assurance; Harmonisation; Laboratory management; Post analytical; Pre analytical; Total testing process

Indexed keywords

ANALYTIC METHOD; ANALYTICAL PARAMETERS; ANALYTICAL PHASE; ARTICLE; CLINICAL LABORATORY; CLINICAL PRACTICE; GOOD LABORATORY PRACTICE; HARMONIZATION; HEALTH CARE QUALITY; HUMAN; INTERHOSPITAL COOPERATION; LABORATORY TEST; PATIENT CARE; PATIENT IDENTIFICATION; POST ANALYTICAL PHASE; POST POST ANALYTICAL PHASE; PRACTICE GUIDELINE; PRE ANALYTICAL PHASE; PRE PRE ANALYTICAL PHASE; PRIORITY JOURNAL; SAMPLING; STANDARDIZATION; DIAGNOSTIC PROCEDURE; METHODOLOGY; QUALITY CONTROL; STANDARD; STANDARDS;

CLINICAL LABORATORY TECHNIQUES; HUMANS; QUALITY CONTROL; REFERENCE STANDARDS; RESEARCH DESIGN;

EID: 84901603506     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.12.005     Document Type: Article

References (80)

1. Plebani M., Laposata M., Lundberg G.D. The brain-to-brain loop concept for laboratory testing 40years after its introduction. Am J Clin Pathol 2011, 136:829-833.
2. Plebani M. Harmonization in laboratory medicine: the complete picture. Clin Chem Lab Med 2013, 51:741-751.
3. Tate J.R., Johnson R., Legg M. Harmonisation of laboratory testing. Clin Biochem Rev 2012, 33:81-84.
4. Aakre K.M., Langlois M.R., Watine J., et al. Critical review of laboratory investigations in clinical practice guidelines: proposals for the description of investigation. Clin Chem Lab Med 2013, 51:1217-1226.
5. Apple F.S., Saenger A.K. The state of cardiac troponin assays: looking bright and moving in the right direction. Clin Chem 2013, 59:1014-1016.
6. Golemboski K. Improving patient safety: lessons from other disciplines. Clin Lab Sci 2011, 24:114-119.
7. Laposata M., Dighe A. "Pre-pre" and "post-post" analytical error: high-incidence patient safety hazards involving the clinical laboratory. Clin Chem Lab Med 2007, 45:712-719.
8. Carraro P., Zago T., Plebani M. Exploring the initial steps of the testing process: frequency and nature of pre-preanalytic errors. Clin Chem 2012, 58:638-642.
9. Sciacovelli L., O'Kane M., Skaik Y.A., et al. Quality indicators in laboratory medicine: from theory to practice. Preliminary data from the IFCC Working Group Project "laboratory errors and patient safety". Clin Chem Lab Med 2011, 49:835-844.
10. Key Incident Monitoring & Management Systems (KIMMS) project [Accessed May 2013]. http://www.rcpaqap.com.au/kimms/.
11. Greg Miller W., Myers G.L., Lou Gantzer M., et al. Roadmap for harmonization of clinical laboratory measurement procedures. Clin Chem 2011, 57:1108-1117.
12. Plebani M., Chiozza M.L., Sciacovelli L. Towards harmonization of quality indicators in laboratory medicine. Clin Chem Lab Med 2013, 51:187-195.
13. Salinas M., Lopez-Garrigos M., Diaz J., et al. Regional variations in test requiring patterns of general practitioners in Spain. Ups J Med Sci 2011, 116:247-251.
14. Salinas M., Lopez-Garrigos M., Uris J., The Pilot Group of the Appropriate Utilization of Laboratory Tests Working Group Differences in laboratory requesting patterns in emergency department in Spain. Ann Clin Biochem 2013, 50:353-359.
15. O'Kane M.J., Casey L., Lynch P.L., McGowan N., Corey J. Clinical outcome indicators, disease prevalence and test request variability in primary care. Ann Clin Biochem 2011, 48:155-158.
16. Monsen A.L., Gjelsvik R., Kaarboe O., Haukland H.H., Sandberg S. Appropriate use of laboratory tests-medical aspects. Tidsskr Nor Laegeforen 2008, 128:810-813.
17. Mindemark M., Larsson A. Longitudinal trends in laboratory test utilization at a large tertiary care university hospital in Sweden. Ups J Med Sci 2011, 116:34-38.
18. Gjelsvik R., Kaarboe O., Haukland H.H., Monsen A.L., Sandberg S. Riktigere bruk av laboratorietjenester-økonomiske aspekter. Tidsskr Nor Laegeforen 2008, 45:2822-2825.
19. Verboeket-van de Venne W.P., Aakre K.M., Watine J., Oosterhuis W.P. Reflective testing: adding value to laboratory testing. Clin Chem Lab Med 2012, 50:1249-1252.
20. Srivastava R., Bartlett W.A., Kennedy I.M., Hiney A., Fletcher C., Murphy M.J. Reflex and reflective testing: efficiency and effectiveness of adding on laboratory tests. Ann Clin Biochem 2010, 47:223-227.
21. Simpson W.G., Twomey P.J. Reflective testing. J Clin Pathol 2004, 57:239-240.
22. Chu K.H., Wagholikar A.S., Greenslade J.H., O'Dwyer J.A., Brown A.F. Sustained reductions in emergency department laboratory test orders: impact of a simple intervention. Postgrad Med J 2013, 89:566-571.
23. Lang T. Laboratory demand management of repetitive testing-time for harmonisation and an evidenced based approach. Clin Chem Lab Med 2013, 51:1139-1140.
24. Janssens P.M., Wasser G. Managing laboratory test ordering through test frequency filtering. Clin Chem Lab Med 2013, 51:1207-1215.
25. Massambu C., Mwangi C. The Tanzania experience: clinical laboratory testing harmonization and equipment standardization at different levels of a tiered health laboratory system. Am J Clin Pathol 2009, 131:861-866.
26. Smellie W.S. Time to harmonise common laboratory test profiles. BMJ 2012, 344:e1169.
27. World Health Organisation (WHO) Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Abbreviated report of a WHO consultation. WHO/NMH/CHP/CPM/11.1 ed 2011, WHO, Geneva.
28. The International Expert Committee Report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009, 32:1327-1334.
29. Aarsand A.K., Villanger J.H., Stole E., et al. European specialist porphyria laboratories: diagnostic strategies, analytical quality, clinical interpretation, and reporting as assessed by an external quality assurance program. Clin Chem 2011, 57:1514-1523.
30. Valenstein P.N., Raab S.S., Walsh M.K. Identification errors involving clinical laboratories: a College of American Pathologists Q-Probes study of patient and specimen identification errors at 120 institutions. Arch Pathol Lab Med 2006, 130:1106-1113.
31. Singla P., Parkash A.A., Bhattacharjee J. Preanalytical error occurrence rate in clinical chemistry laboratory of a public hospital in India. Clin Lab 2011, 57:749-752.
32. Hawkins R. Managing the pre- and post-analytical phases of the total testing process. Ann Lab Med 2012, 32:5-16.
33. Gomez-Rioja R., Fernandez-Calle P., Alcaide M.J., et al. Interindividual variability of hemolysis in plasma samples during pneumatic tube system transport. Clin Chem Lab Med 2013, 10:e231-e233.
34. Kavsak P.A., Mansour M., Wang L., et al. Assessing pneumatic tube systems with patient-specific populations and laboratory-derived criteria. Clin Chem 2012, 58:792-795.
35. Streichert T., Otto B., Schnabel C., et al. Determination of hemolysis thresholds by the use of data loggers in pneumatic tube systems. Clin Chem 2011, 57:1390-1397.
36. Felder R.A. Preanalytical errors introduced by sample-transportation systems: a means to assess them. Clin Chem 2011, 57:1349-1350.
37. Stephan C., Siemssen K., Cammann H., et al. Between-method differences in prostate-specific antigen assays affect prostate cancer risk prediction by nomograms. Clin Chem 2011, 57:995-1004.
38. McLawhon R.W. Patient safety and clinical effectiveness as imperatives for achieving harmonization inside and outside the clinical laboratory. Clin Chem 2011, 57:936-938.
39. Clinical laboratory test harmonization [Accessed July 2013]. http://www.harmonization.net/Pages/default.aspx.
40. Miller W.G., Jones G.R.D., Horowitz G.L., Weykamp C. Proficiency testing/external quality assessment: current challenges and future directions. Clin Chem 2011, 57:1670-1680.
41. Miller W.G., Erek A., Cunningham T.D., Oladipo O., Scott M.G., Johnson R.E. Commutability limitations influence quality control results with different reagent lots. Clin Chem 2011, 57:76-83.
42. Stavelin A., Petersen P.H., Solvik U.O., Sandberg S. External quality assessment of point-of-care methods: model for combined assessment of method bias and single-participant performance by the use of native patient samples and noncommutable control materials. Clin Chem 2013, 59:363-371.
43. Panteghini M. Application of traceability concepts to analytical quality control may reconcile total error with uncertainty of measurement. Clin Chem Lab Med 2010, 48:7-10.
44. Van Houcke S.K., Rustad P., Stepman H.C., et al. Calcium, magnesium, albumin, and total protein measurement in serum as assessed with 20 fresh-frozen single-donation sera. Clin Chem 2012, 58:1597-1599.
45. European Organisation for External Quality Assurance Providers in Laboratory Medicine (EQALM) [Accessed August 2013]. http://www.eqalm.org/.
46. Gomez-Rioja R., Alvarez V., Ventura M., et al. Current status of verification practices in clinical biochemistry in Spain. Clin Chem Lab Med 2013, 51:1739-1746.
47. Deetz C.O., Nolan D.K., Scott M.G. An examination of the usefulness of repeat testing practices in a large hospital clinical chemistry laboratory. Am J Clin Pathol 2012, 137:20-25.
48. Aarsand A.K. Improving pre-analytical, analytical and post-analytical phase by EQAS -examples. Biochem Med (Zagreb) 2012, 22(3):S13-1.
49. Rustad P., Felding P., Lahti A. Proposal for guidelines to establish common biological reference intervals in large geographical areas for biochemical quantities measured frequently in serum and plasma. Clin Chem Lab Med 2004, 42:783-791.
50. Hyltoft Petersen P., Rustad P. Prerequisites for establishing common reference intervals. Scand J Clin Lab Invest 2004, 64:285-292.
51. Ozarda Y., Ichihara K., Barth J.H., et al. Protocol and standard operating procedures for common use in a worldwide multicenter study on reference values. Clin Chem Lab Med 2013, 51:1027-1040.
52. Panteghini M., Ceriotti F. Obtaining reference intervals traceable to reference measurement systems: is it possible, who is responsible, what is the strategy?. Clin Chem Lab Med 2012, 50:813-817.
53. Felding P., Rustad P., Martensson A., et al. Reference individuals, blood collection, treatment of samples and descriptive data from the questionnaire in the Nordic Reference Interval Project 2000. Scand J Clin Lab Invest 2004, 64:327-342.
54. Rustad P., Felding P., Franzson L., et al. The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties. Scand J Clin Lab Invest 2004, 64:271-284.
55. Rustad P., Hyltoft Petersen P. Effect of analytical quality on establishing common reference intervals and their use. Scand J Clin Lab Invest 2004, 64:399-406.
56. Pathology harmony [Accessed August 2013]. http://www.pathologyharmony.co.uk/.
57. Barlow I.M. Are biochemistry interpretative comments helpful? Results of a general practitioner and nurse practitioner survey. Ann Clin Biochem 2008, 45:88-90.
58. Plebani M. Interpretative commenting: a tool for improving the laboratory-clinical interface. Clin Chim Acta 2009, 404:46-51.
59. Laposata M.E., Laposata M., Van Cott E.M., Buchner D.S., Kashalo M.S., Dighe A.S. Physician survey of a laboratory medicine interpretive service and evaluation of the influence of interpretations on laboratory test ordering. Arch Pathol Lab Med 2004, 128:1424-1427.
60. Lim E.M., Sikaris K.A., Gill J., et al. Quality assessment of interpretative commenting in clinical chemistry. Clin Chem 2004, 50:632-637.
61. Aakre K.M., Oosterhuis W.P., Sandberg S. How do laboratory specialists advise clinicians concerning the use and interpretation of renal tests?. Scand J Clin Lab Invest 2012, 72:143-151.
62. Sciacovelli L., Zardo L., Secchiero S., Zaninotto M., Plebani M. Interpretative comments and reference ranges in EQA programs as a tool for improving laboratory appropriateness and effectiveness. Clin Chim Acta 2003, 333:209-219.
63. Marshall W.J., Challand G.S. Provision of interpretative comments on biochemical report forms. Ann Clin Biochem 2000, 37(Pt 6):758-763.
64. Claustres M., Kozich V., Dequeker E., et al. Recommendations for reporting results of diagnostic genetic testing (biochemical, cytogenetic and molecular genetic). Eur J Hum Genet 2013 Aug 14, [Epub ahead of print]. 10.1038/ejhg.2013.125.
65. European Molecular Genetics Quality Network (EMQN) [Accessed August 2013]. http://www.emqn.org/emqn/Home.
66. Campbell C., Horvath A. Towards harmonisation of critical laboratory result management -review of the literature and survey of Australasian practices. Clin Biochem Rev 2012, 33:149-160.
67. Chhillar N., Khurana S., Agarwal R., Singh N.K. Effect of pre-analytical errors on quality of laboratory medicine at a neuropsychiatry institute in north India. Indian J Clin Biochem 2011, 26:46-49.
68. Piva E., Plebani M. From "panic" to "critical" values: which path toward harmonization?. Clin Chem Lab Med 2013, 51:2069-2071.
69. European Federation of Clinical Chemistry, Medicine Laboratory Task and Finish Group on Critical Results [Accessed August 2013]. http://www.efcclm.org/index.php/tasks-and-finish-group-on-critical-results-tfg-cr.html.
70. Callen J., Georgiou A., Li J., Westbrook J.I. The safety implications of missed test results for hospitalised patients: a systematic review. BMJ Qual Saf 2011, 20:194-199.
71. Callen J.L., Westbrook J.I., Georgiou A., Li J. Failure to follow-up test results for ambulatory patients: a systematic review. J Gen Intern Med 2012, 27:1334-1348.
72. Skeie S., Perich C., Ricos C., et al. Postanalytical external quality assessment of blood glucose and hemoglobin A1c: an international survey. Clin Chem 2005, 51:1145-1153.
73. Aakre K.M., Thue G., Subramaniam-Haavik S., et al. Postanalytical external quality assessment of urine albumin in primary health care: an international survey. Clin Chem 2008, 54:1630-1636.
74. Kristoffersen A.H., Thue G., Ajzner E., et al. Interpretation and management of INR results: a case history based survey in 13 countries. Thromb Res 2012, 130:309-315.
75. Diabetes Association American Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, S62-S69.
76. Sacks D.B., Arnold M., Bakris G.L., et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2011, 57:e1-e47.
77. Berg J.P., Berg T.J., Bjerve K.S., et al. Rapport fra arbeidsgruppe for vurdering av diagnostisk bruk av HbA1c ved diabetes [Accessed July 2013]. http://legeforeningen.no/PageFiles/104318/HbA1c%20til%20diagnostikk%20av%20diabetes.pdf.
78. Helsedirektoratet HbA1c som diagnostikum for diabetes [Accessed July 2013]. http://helsedirektoratet.no/Om/nyheter/Documents/blodproven-hba1c-som-diagnostikum-for-diabetes.pdf.
79. Solvik U.O., Roraas T., Christensen N.G., Sandberg S. Diagnosing diabetes mellitus: performance of hemoglobin A1c point-of-care instruments in general practice offices. Clin Chem 2013, [Epub ahead of print]. 10.1373/clinchem.2013.210781.
80. Bayley C. Medical mistakes and institutional culture. Accountability: patient safety and policy reform 2004, 99-117. Georgetown University Press, Washington D.C. V.A. Sharpe (Ed.).